News
$BriaCell Therapeutics (BCTX.US)$ BriaCell Quadruples Progression Free Survival (PFS) in Patient with "Eye-Bulging" Metastatic Breast Cancer
3 MINUTES AGO, 7:56 AM EDT
VIA GLOBENEWSWIRE
BCTXBCTXW
SHARE
• Progression free survival (PFS) extended to 9.1 months in ADC resistant patient - quadruple the PFS of patients in similar studies 1, 2, 3
• Significant reduction of "Eye-Bulging" metastatic breast cancer tumor was previously reported
• Heavily pre-treated patient had failed 8 prior regimens including antibody-drug conjugate (ADC) therapy and continues to receive BriaCell treatment
3 MINUTES AGO, 7:56 AM EDT
VIA GLOBENEWSWIRE
BCTXBCTXW
SHARE
• Progression free survival (PFS) extended to 9.1 months in ADC resistant patient - quadruple the PFS of patients in similar studies 1, 2, 3
• Significant reduction of "Eye-Bulging" metastatic breast cancer tumor was previously reported
• Heavily pre-treated patient had failed 8 prior regimens including antibody-drug conjugate (ADC) therapy and continues to receive BriaCell treatment
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
